Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.Qujiang Wenlv: It received a warning letter from Shaanxi Supervision Bureau, and Qujiang Wenlv announced that the company received the Decision on Taking Measures to Issue Warning Letters to Xi 'an Qujiang Cultural Tourism Co., Ltd., Xie Xiaoning and Xi 'an Qujiang Tourism Investment Co., Ltd. issued by Shaanxi Supervision Bureau of China Securities Regulatory Commission on December 10, 2024. After investigation, the company delayed the disclosure of the major event that 8.23% of the company's shares held by the controlling shareholder Xi 'an Qujiang Tourism Investment Co., Ltd. were to be disposed of by the judiciary, which violated the relevant provisions of the Measures for the Administration of Information Disclosure of Listed Companies. According to Article 52 of the Measures, Shaanxi Supervision Bureau decided to take administrative supervision measures to issue warning letters to the company, Xie Xiaoning, the relevant responsible person, and Qujiang Travel Investment, the controlling shareholder. The company will seriously rectify, strengthen information disclosure and corporate governance, and improve the operation level and information disclosure quality.ZTE and ZTE Xinyun jointly released a digital intelligence financial solution. Recently, ZTE and ZTE Xinyun Cloud Service Co., Ltd. (referred to as "ZTE Xinyun") jointly released a digital intelligence financial solution based on digital nebula. The solution provides one-stop financial cloud application, fully supports financial functions and financial processes, solves breakpoints and pain points in the interaction between industry and finance, breaks the "data island" between systems, realizes the intelligent and efficient collection of business data and financial processing, and empowers the intelligent transformation of enterprise financial data.
Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Sarah Friar, CFO of OpenAI: Corporate customers will pay (at least) thousands of dollars for using artificial intelligence (AI) tools. In the end, it will be reasonable.Nine associations, including China Consumers Association and internet society of china, China Hotel Association, China Self-employed Workers Association, china electronic chamber of commerce, China Packaging Federation, China Chain Store & Franchise Association, China Baked Food and Sugar Products Industry Association and China Nutrition Society, jointly proposed on December 11 to encourage catering industry operators (including self-employed workers) to curb catering waste in the industry through innovative measures, public welfare publicity and optimized services.
Trump said that he chose Andrew Feargus, Commissioner of the US Federal Trade Commission (FTC), as the FTC chairman.Japanese manufacturers' confidence index turned negative to the central bank's forecast in December. A short-term survey in Reuters, Japan, found that Japanese manufacturers' business confidence deteriorated further in December due to concerns about US protectionist policies. The survey of 505 large Japanese non-financial enterprises showed that manufacturers' confidence index fell from 5 in November to -1 in December, which was the first time since last February, and the number of pessimists exceeded optimists for the first time in 10 months. The loss of business confidence may cast a shadow over the Bank of Japan's forecast. The Bank of Japan had previously predicted that a steady recovery driven by rising wages and consumption would help inflation reach the 2% target in a sustainable way and justify further interest rate hikes. Many manufacturing industries have reported that business confidence has declined. Among electronic machinery manufacturers, steel and non-ferrous metal manufacturers, pessimists far exceed optimists.Zhongzhou Special Materials: Shareholders have transferred and reduced their shares by more than 1%. Zhongzhou Special Materials announced that shareholders holding more than 5% have transferred their shares internally and reduced their shares by more than 1%. After the shareholder completed the internal transfer among the concerted parties, its shareholding ratio changed accordingly. At the same time, the shareholder reduced his shares through the secondary market, and the reduction ratio exceeded 1%. This share change is mainly for the adjustment of shareholding within the company's shareholders, and will not have a significant impact on the company's governance structure and daily operations.